EPIX is currently conducting clinical trials for Alzheimer's disease. For more information, please visit http://www.trialforad.com.

For information about the PRX-03140 Phase 2a data, please call 866-514-2901.

November 11, 2008
EPIX Pharmaceuticals Receives NASDAQ Compliance Notice; Intends to Request Hearing

November 4, 2008
EPIX Pharmaceuticals Announces Third Quarter Financial Results

October 28, 2008
EPIX Pharmaceuticals Announces Third Quarter 2008 Financial Results Release Date and Conference Call